5 results
To determine the pharmacokinetic properties of a new elacridar formulation
The primary objective of this study is to obtain clinical proof of principle that the addition of a PgP/BCRP inhibitor increases CNS concentrations of tyrosine kinase inhibitors by inhibition of drug efflux transporter function in the blood brain…
Primary objective: to asses the quality of a reservoir which removes leukocytes and lipids combined with the Continuous Autotransfusion System (CATS) regarding the autotransfusion product in general and red blood cell function in particular.…
In this study we aim to evaluate the feasibility of a mobile application guiding IBD patients during biologic treatment.
In this study we will assess the (cost)effectiveness of a transmural integrated care programme supporting return to daily activities (including work)after knee arthroplasty compared to usual care. We hypothesize our transmural integrated care…